MagChip CT/NGS-CRO/TV/MGS-AZM
The first MagChip cartridge is designed for the detection of four key sexually transmitted infections (STIs):
It also determines antimicrobial susceptibility for:
This innovative test addresses the undervalued sexually transmitted infection (STI) epidemic, providing simultaneous STI + antimicrobial susceptibility results in < 20 minutes. With faster detection and susceptibility-guided insights, the MagChip enables earlier and more informed triage and treatment decisions, leading to better patient outcomes by reducing transmission, reinfection, and adverse reproductive health complications.
*The MagIC MagChipR and MagChip have not been approved or cleared by the U.S. Food and Drug Administration or any other regulatory authority. The performance characteristics of these devices have not been established.
Simultaneous STI + AMR actionable results < 20 minutes
◦ Chlamydia trachomatis (CT)
◦ Neisseria gonorrhoeae (NG)
◦ Trichomonas vaginalis (TV)
◦ Mycoplasma genitalium (MG)
◦ Ceftriaxone-susceptible Neisseria gonorrhoeae (NGS-CRO)
◦ Azithromycin-susceptible Mycoplasma genitalium (MGS-AZM)
Designed to accept sample types
Oral swab
Urine sample
Vaginal swab
Rectal swab
Sample-to-Results Workflow
MagChipR Platform provides:
Sample lysis
Nucleic acid hybridization
A simple, clean, and minimalistic user workflow
PCR amplification
Detection of target sequences
Determination of antimicrobial susceptibility
Fast time-to-results during appointment
Obtains multiple results from one sample
Eliminates empiric treatment
Promotes antimicrobial stewardship
Eliminates patient loss to follow-up
Enables expedited partner therapy
Increases patient satisfaction
Affordable
Contact Us
© 2025 Magic Lifescience Inc
All Rights Reserved.
MagIC Lifescience, MagIC Lifescience logo, Creating MagIC®, MagChipR™, MagChip™, and Just Chip It™ are registered trademarks of MagIC Lifescience, Inc.
LBL-00002 rev A
